CAS 842133-18-0
:Canagliflozin
Description:
Canagliflozin is a medication primarily used in the management of type 2 diabetes mellitus. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which function by preventing the reabsorption of glucose in the kidneys, thereby promoting its excretion in urine and lowering blood glucose levels. The chemical formula for Canagliflozin is C21H25ClO5S, and it features a sulfonyl group, a chlorobenzene moiety, and a glucose-like structure, which contribute to its pharmacological activity. Canagliflozin is typically administered orally and is known for its potential benefits beyond glycemic control, including weight loss and cardiovascular protection. Common side effects may include urinary tract infections and dehydration. As with any medication, it is essential for patients to consult healthcare professionals for personalized advice and monitoring while using Canagliflozin.
Formula:C24H25FO5S
InChI:InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1
InChI key:InChIKey=XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
SMILES:O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC=3SC(=CC3)C4=CC=C(F)C=C4)=C(C)C=C2
Synonyms:- (1S)-1,5-Anhydro-1-C-(3-((5-(4-Fluorophenyl)-2-Thienyl)Methyl)-4-Methylphenyl)-D-Glucitol
- (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-<span class="text-smallcaps">D</span>-glucitol
- 1-(β-<span class="text-smallcaps">D</span>-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene
- 1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene
- <span class="text-smallcaps">D</span>-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
- Canaglifozin
- Invokana
- Jnj 24831754Zae
- Jnj 28431754
- Jnj 28431754Aaa
- Ta 7284
- Canagliflozin
- D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-
- D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl
- (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
- Canagliflozi
- Cango coluMn net
- Canagliflozin WS
- Canagliflozin, >=98%
- Canaglifozion
- Canagliflozin-D6
- Canagliflozin(TA-7284)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
Canagliflozin
CAS:Formula:C24H25FO5SPurity:≥ 98.0%Color and Shape:White to yellow solidMolecular weight:444.52Canagliflozin
CAS:<p>Canagliflozin (JNJ 28431754AAA) is a selective SGLT2 inhibitor. Canagliflozin is used to treat type II diabetes mellitus. Cost-effective and quality-assured.</p>Formula:C24H25FO5SPurity:98.01% - >99.99%Color and Shape:SolidMolecular weight:444.52Canagliflozin
CAS:Controlled Product<p>Applications Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.<br>References Chao, E. et al.: Drug Fut., 36, 351 (2011); Sha, S. et al.: Diab. Obes. Metab., 13, 669 (2011); Kipnes, M.S.: Clin. Invest., 1, 145 (2011);<br></p>Formula:C24H25FO5SColor and Shape:ColourlessMolecular weight:444.521,5-Dihydroxy Canagliflozin
CAS:Controlled ProductFormula:C24H27FO6SColor and Shape:NeatMolecular weight:462.531Canagliflozin
CAS:<p>Canagliflozin is a drug that has been approved for the treatment of type 2 diabetes. It is an inhibitor of sodium glucose transporter 2 (SGLT2) and reduces blood glucose levels by increasing urinary glucose excretion. Canagliflozin has been shown to have cardiac effects, which may be due to its ability to increase serum natriuretic peptide levels and decrease heart rate. This drug has also been shown to reduce cardiovascular disease activity in patients with type 2 diabetes. Canagliflozin is not active against c. glabrata, but it does inhibit SGLT1 in this organism.</p>Formula:C24H25FO5SPurity:Min. 95%Color and Shape:PowderMolecular weight:444.52 g/mol2'-Deshydroxymethyl-2'-Chloromethyl-6'-methoxy-canagliflozin
CAS:Controlled ProductFormula:C25H26ClFO5SColor and Shape:NeatMolecular weight:492.9872'-Deshydroxymethyl-2'-Chloromethyl-canagliflozin
CAS:Controlled ProductFormula:C24H24ClFO4SColor and Shape:NeatMolecular weight:462.961(3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
CAS:Controlled ProductFormula:C25H27FO6SColor and Shape:NeatMolecular weight:474.542Canagliflozin Tetra-acetyloxy
CAS:Controlled ProductFormula:C32H33FO9SColor and Shape:NeatMolecular weight:612.662(2R,3R,4R,5R)-1-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2,3,4,5,6-pentahydroxyhexan-1-one
CAS:Controlled ProductFormula:C24H25FO6SColor and Shape:NeatMolecular weight:460.515








